Novel and Traditional Risk Factors for Symptomatic PAD in Women
女性症状性 PAD 的新的和传统的危险因素
基本信息
- 批准号:7210720
- 负责人:
- 金额:$ 13.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-20 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:Alcohol consumptionAlteplaseAmericanAntigensAntioxidantsApolipoproteinsApolipoproteins BAreaAspirinAtherosclerosisAwardBehavioralBiological MarkersBloodBlood BanksBlood PressureBlood specimenBody fatBostonC-reactive proteinCarbohydratesCardiovascular DiseasesCardiovascular systemCarotenoidsClinicalControlled Clinical TrialsCreatinineCross-Sectional StudiesDataData CollectionDevelopmentDiabetes MellitusDiet ModificationDietary FiberDiseaseDoseEnrollmentEnvironmentEpidemiologic StudiesEpidemiologyEvaluationFatty acid glycerol estersFellowshipFibrin fragment DFibrinogenFolateFoundationsFundingGlycosylated hemoglobin AGrantGroup ProcessesHealth ProfessionalHigh Density Lipoprotein CholesterolHomocysteineHomocystineHospitalsIncidenceInflammationIntakeIntercellular adhesion molecule 1Intermittent ClaudicationInterventionKnowledgeLife StyleLipoprotein (a)Lipoprotein (a-)Low-Density LipoproteinsLower ExtremityMalignant NeoplasmsMeasurementObesityOperative Surgical ProceduresParticipantPatient Self-ReportPeripheralPeripheral arterial diseasePhysical activityPlacebo ControlPlasmaPopulationPostdoctoral FellowPreventionPreventive MedicinePrimary PreventionProcessProtein CPublishingRandomizedRangeRenal functionResearchResearch ActivityResearch PersonnelRiskRisk AssessmentRisk EstimateRisk FactorsSample SizeScientistSmokingSourceSystemThrombosisTimeTrainingUnited States National Institutes of HealthVitamin B ComplexVitamin EWomanWomen&aposs Healthabstractingagedbasecardiovascular disorder preventioncardiovascular risk factorcareercohortcostdesigndietary antioxidantfollow-upinterestlipid metabolismmenmiddle agemodifiable risknon-diabeticnovelprogramsprospectiverepositoryskills
项目摘要
DESCRIPTION (provided by applicant):
This project will prepare the candidate, Dr. Aruna Pradhan, for a career as an independent clinical scientist in cardiovascular epidemiology with a focus on risk assessment of peripheral arterial disease (PAD), her area of scientific interest. At the time of award activation, Dr. Pradhan will be a board eligible cardiologist having completed her fellowship training at the Brigham and Women's Hospital (BWH), Boston. Her post-doctoral research activities have been undertaken in the Center for Cardiovascular Disease Prevention within the Division of Preventive Medicine, BWH. The Center provides a scientifically productive environment for the support of junior investigators in the conduct of population-based epidemiologic research. The applicant proposes a 5-year program of research that will prospectively evaluate novel and traditional risk factors for PAD in women, among whom limited epidemiologic data exist. The risk factors to be examined may be categorized into one of three groups: novel biomarkers, traditional and behavioral cardiovascular risk factors, and dietary influences. Employing a prospective cohort design, analyses will be conducted in the Women's Health Study of 39,876 healthy middle-aged American women. The long-term follow-up and high quality covariate data in this cohort offer a unique opportunity to study, in a prospective manner, potentially modifiable risk factors for PAD in a large well-characterized population of women. At the conclusion of the award period, Dr. Pradhan will have acquired advanced epidemiologic skills and expertise in the study of PAD which will enable her to independently conduct research in prevention and treatment of this disease. This proposal seeks to evaluate the association between a broad range of emerging and traditional risk factors and the development of atherosclerosis in the lower extremity arterial system among American women. While prior limited data are available pertaining to these risk factors in men, information with regard to risk factor relationships in women are extremely sparse. Specific exposures of interest include blood based biomarkers, traditional cardiovascular risk factors such as diabetes, obesity, and elevated blood pressure, behavioral risk factors such as smoking and physical inactivity, and dietary influences such as fat, antioxidant, and carbohydrate intake. (End of Abstract)
描述(由申请人提供):
该项目将为候选人Aruna Pradhan博士做好准备,成为心血管流行病学独立临床科学家的职业,重点是对外周动脉疾病(PAD)的风险评估,这是她的科学意义领域。在激活奖励时,Pradhan博士将是一名合格的心脏病专家,他在波士顿的Brigham and妇女医院(BWH)完成了奖学金培训。她的博士后研究活动是在预防医学分区内的心血管疾病预防中心进行的。该中心为基于人群的流行病学研究提供了一个科学生产的环境,以支持初级研究人员的支持。申请人提出了一项为期5年的研究计划,该计划将前瞻性评估女性PAD的新颖和传统危险因素,其中包括流行病学数据有限。要检查的危险因素可以分为三组之一:新型生物标志物,传统和行为心血管危险因素以及饮食影响。采用前瞻性队列设计,将在39,876名健康中年妇女的妇女健康研究中进行分析。该队列中的长期随访和高质量的协变量数据为在大量良好的妇女人群中以前瞻性修改的危险因素进行研究提供了独特的机会。在奖励期结束时,Pradhan博士将在PAD研究中获得高级流行病学技能和专业知识,这将使她能够独立进行预防和治疗这种疾病的研究。该提案旨在评估美国妇女中下肢动脉系统中广泛的新兴和传统危险因素与动脉粥样硬化的发展之间的关联。虽然先前的有限数据与男性中的这些风险因素有关,但关于女性风险因素关系的信息极为稀疏。感兴趣的特定暴露包括基于血液的生物标志物,传统的心血管危险因素,例如糖尿病,肥胖和血压升高,行为危险因素,例如吸烟和身体不活跃,以及饮食影响,例如脂肪,抗氧化剂和碳水化合物的摄入量。 (抽象的结尾)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aruna Das Pradhan其他文献
HYPERTRIGLYCERIDEMIA, INFLAMMATION, HYPERCHOLESTEROLEMIA, AND FUTURE CARDIOMETABOLIC DISEASE RISK: A DATA DRIVEN CLUSTER ANALYSIS IN THE WOMEN's HEALTH STUDY
- DOI:
10.1016/s0735-1097(20)32490-6 - 发表时间:
2020-03-24 - 期刊:
- 影响因子:
- 作者:
Edward Duran;Nancy R. Cook;Aaron W. Aday;Julie E. Buring;Paul M. Ridker;Aruna Das Pradhan - 通讯作者:
Aruna Das Pradhan
Effect of Pemafibrate on Diabetic Foot Ulceration and Gangrene: An Exploratory Analysis From PROMINENT
- DOI:
10.1016/j.jacc.2024.05.028 - 发表时间:
2024-07-23 - 期刊:
- 影响因子:
- 作者:
Lucas L. Marinho;Brendan M. Everett;Aaron W. Aday;Frank L.J. Visseren;Jean G. MacFadyen;Elaine Zaharris;Jorge Plutzky;Raul D. Santos;Peter Libby;Jean-Charles Fruchart;Paul M Ridker;Aruna Das Pradhan - 通讯作者:
Aruna Das Pradhan
TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLES, RACE/ETHNIC GROUP AND FUTURE CARDIOVASCULAR EVENTS:THE MESA STUDY
- DOI:
10.1016/s0735-1097(22)02544-x - 发表时间:
2022-03-08 - 期刊:
- 影响因子:
- 作者:
Edward Duran;David R. Jacobs;Aruna Das Pradhan;Aaron W. Aday;Daniel A. Duprez - 通讯作者:
Daniel A. Duprez
Aruna Das Pradhan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aruna Das Pradhan', 18)}}的其他基金
Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD
小剂量甲氨蝶呤抗炎治疗可减少 PAD
- 批准号:
9272427 - 财政年份:2014
- 资助金额:
$ 13.55万 - 项目类别:
Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD
小剂量甲氨蝶呤抗炎治疗可减少 PAD
- 批准号:
8738800 - 财政年份:2014
- 资助金额:
$ 13.55万 - 项目类别:
Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD
小剂量甲氨蝶呤抗炎治疗可减少 PAD
- 批准号:
8913257 - 财政年份:2014
- 资助金额:
$ 13.55万 - 项目类别:
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
JUPITER 中他汀类药物诱发 DM 的机制(用于预防 CVD 的瑞舒伐他汀)
- 批准号:
8286969 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Diabetes Prevention in the Vitamin D and Omega-3 Trial
维生素 D 和 Omega-3 试验中的糖尿病预防
- 批准号:
8516502 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
JUPITER 中他汀类药物诱发 DM 的机制(用于预防 CVD 的瑞舒伐他汀)
- 批准号:
7946012 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
JUPITER 中他汀类药物诱发 DM 的机制(用于预防 CVD 的瑞舒伐他汀)
- 批准号:
8507268 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Diabetes Prevention in the Vitamin D and Omega-3 Trial
维生素 D 和 Omega-3 试验中的糖尿病预防
- 批准号:
8689001 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
JUPITER 中他汀类药物诱发 DM 的机制(用于预防 CVD 的瑞舒伐他汀)
- 批准号:
8123463 - 财政年份:2010
- 资助金额:
$ 13.55万 - 项目类别:
Novel and Traditional Risk Factors for Symptomatic PAD in Women
女性症状性 PAD 的新的和传统的危险因素
- 批准号:
7762747 - 财政年份:2006
- 资助金额:
$ 13.55万 - 项目类别:
相似海外基金
Low-Dose Magneto-Thrombolysis to Expand Stroke Care
低剂量磁溶栓扩大中风治疗范围
- 批准号:
10693650 - 财政年份:2023
- 资助金额:
$ 13.55万 - 项目类别:
Comparative testing of tatCN19o for neuroprotection in rodent tMCAo
tatCN19o 对啮齿动物 tMCAo 神经保护作用的比较测试
- 批准号:
10671969 - 财政年份:2023
- 资助金额:
$ 13.55万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 13.55万 - 项目类别:
Dodecafluoropentane emulsion (DDFPe), NanO2™ as Cerebroprotectant in Ischemic Stroke
十二氟戊烷乳液 (DDFPe)、NanO2™ 作为缺血性中风的脑保护剂
- 批准号:
10591442 - 财政年份:2023
- 资助金额:
$ 13.55万 - 项目类别:
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)
血压变异性和缺血性中风结果 (BP-VISO)
- 批准号:
10564945 - 财政年份:2023
- 资助金额:
$ 13.55万 - 项目类别: